Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RGS12 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GART - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NARF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GALNT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIAPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KIAA0391 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETDB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSX2IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HP1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APIP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDAH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRAK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STIM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NCOA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on